Søg i kliniske forsøg efter: Fokus på røgfrit liv: tankesæt og beslutninger
I alt 1 resultater
-
University of FloridaNational Institute on Drug Abuse (NIDA)Afsluttet
Denne side blev automatisk oversat, og nøjagtigheden af oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.
Sponsorer og samarbejdspartnere
- Medical Group Care, LLC
- Rubens da Silva
- Providence Public School District
- BioMAdvanced Diagnostics
- PTC Therapeutics
- Jiangyin Hospital Affiliated to Southeast University School of Medicine
- Hospital Geral de Fortaleza
- University of Illinois at Urbana-Champaign
- Depressie Vereniging (patient association)
- Philip Spinella
- JSR Medical Co., Ltd.
- Henriette Svarre Nielsen, Professor Dept. of Obstetrics and Gynecology, Hvidovre Hospital
- BRUSANO
- Douglas Kwon
- Ensemble contre le SIDA
- Sanfilippo Children's Research Foundation
- Depression and Bipolar Support Alliance
- Villanova University
- Orthopaedic Biomechanics and Biomaterials Laboratory at Massachusetts General Hospital
- Prof. Jacques SCHRENZEL
- Se den fulde liste
Medicinske tilstande
- Hospitalserhvervet tryksår
- STEMI - ST-segment Elevation Myokardieinfarkt
- Kirurgisk patient
- Nyrefunktionsforstyrrelse
- Henfald
- Anaplastisk storcellet lymfom
- Sporadisk
- Optimys lårbensstamme
- Kunstig bugspytkirtel
- PD-1 Refractory Advanced Melanom
- Anatomisk fase 2A brystkræft AJCC v8
- Ekstraartikulær fraktur
- Social angst
- Nakkemasse
- Tobak, alkohol, receptpligtig medicin og ulovlig brug af stoffer
- LAV OVARIERESPONS
- Dislokation, Skulder
- Aldersrelateret høretab
- Nøjagtighed og præcision af ikke-invasiv måling
- Post Covid-19 tilstand
- Se den fulde liste
Narkotikainterventioner
- Camptosar
- THC
- Letrozol
- Intravenøs deferipron
- RDX227675
- Desvenlafaxin
- Olopatadin
- Oxycodon/acetaminophen 5/325 mg
- TPN-101
- Capecitabin/cisplatin
- OnabotulinumtoxinA
- Antikolinergisk
- GLPG1837 flere stigende doser
- Capecitabin og IMRT (hvis randomiseret til denne arm)
- Fospropofol dinatrium, propofol
- MLN2480
- PD-1/PD-L1-hæmmer
- Standardbehandling (SOC) for COVID-19
- Intravenøs formulering af PD-0332991
- Midazolam
- Se den fulde liste
CROs by country
- Contract Research Organizations in Austria
- Contract Research Organizations in Brazil
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Georgia
- Contract Research Organizations in Ireland
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Peru
- Contract Research Organizations in Philippines
- Contract Research Organizations in Slovakia
- Contract Research Organizations in Ukraine
- Contract Research Organizations in United Kingdom
- Contract Research Organizations in Uruguay
- CRO list by country